These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 35356254)

  • 41. Efficacy and safety of apatinib combined with transarterial chemoembolization (TACE) in treating patients with recurrent hepatocellular carcinoma.
    Gu H; Li J; You N; Wu K; Wang Z; Wang L; Zhu Y; Liu Q; Peng X; Zheng L
    Ann Transl Med; 2020 Dec; 8(24):1677. PubMed ID: 33490189
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transhepatectomy combined with arterial chemoembolization and transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a clinical prognostic analysis.
    Liu X; Li H; Wang F; Su K; He B; He J; Zhong J; Han Y; Li Z
    BMC Gastroenterol; 2023 Sep; 23(1):299. PubMed ID: 37670232
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sorafenib Combined with Chemoembolization for Locally Advanced Hepatocellular Carcinoma with Macroscopic Vascular Invasion: A Propensity Score Analysis.
    Kim GH; Choi SL; Kim JH; Shim JH; Alali M; Kim N
    Life (Basel); 2021 Oct; 11(10):. PubMed ID: 34685437
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The PPRD score stratifies patients with hepatocellular carcinoma and portal vein tumor thrombus treated with sorafenib plus transarterial chemoembolization.
    Zhang Y; Miao H; Xie W; Jiang S; Song Z; Huang G; Fan W; Wang Y; Li J; Chen Y
    Eur Radiol; 2021 Jan; 31(1):232-243. PubMed ID: 32728770
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Comparison of therapeutics effects of transcatheter arterial chemoembolization combined with iodine-125 seed implantation and sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis].
    Luo J; Zheng JP; Shao GL; Wen S; Guo LW; Zeng H; Zhang L; Qian CY; Hao WY
    Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):298-304. PubMed ID: 29996343
    [No Abstract]   [Full Text] [Related]  

  • 46. Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Tertiary Care Center Experience.
    Patidar Y; ; Mukund A; Sarin SK
    Indian J Radiol Imaging; 2021 Apr; 31(2):270-276. PubMed ID: 34556907
    [No Abstract]   [Full Text] [Related]  

  • 47. Transcatheter arterial chemoembolization plus apatinib with or without camrelizumab for unresectable hepatocellular carcinoma: a multicenter retrospective cohort study.
    Duan X; Li H; Kuang D; Chen P; Zhang K; Li Y; He X; Xing C; Wang H; Liu Y; Xie L; Zhang S; Zhang Q; Zhu P; Dong H; Xie J; Li H; Wang Y; Shi M; Jiang G; Xu Y; Zhou S; Shang C; Ren J; Han X
    Hepatol Int; 2023 Aug; 17(4):915-926. PubMed ID: 37012542
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of chemoembolization with and without radiation therapy and sorafenib for advanced hepatocellular carcinoma with portal vein tumor thrombosis: a propensity score analysis.
    Kim GA; Shim JH; Yoon SM; Jung J; Kim JH; Ryu MH; Ryoo BY; Kang YK; Lee D; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS
    J Vasc Interv Radiol; 2015 Mar; 26(3):320-9.e6. PubMed ID: 25612807
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transarterial Chemoembolization (TACE) Combined with Sorafenib
    Ren B; Wang W; Shen J; Li W; Ni C; Zhu X
    J Cancer; 2019; 10(5):1189-1196. PubMed ID: 30854128
    [No Abstract]   [Full Text] [Related]  

  • 50. Safety and efficacy of transarterial chemoembolization plus sorafenib for hepatocellular carcinoma with portal venous tumour thrombus.
    Pan T; Li XS; Xie QK; Wang JP; Li W; Wu PH; Zhao M
    Clin Radiol; 2014 Dec; 69(12):e553-61. PubMed ID: 25304928
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transarterial chemoembolization versus best supportive care for patients with hepatocellular carcinoma with portal vein tumor thrombus：a multicenter study.
    Xiang X; Lau WY; Wu ZY; Zhao C; Ma YL; Xiang BD; Zhu JY; Zhong JH; Li LQ
    Eur J Surg Oncol; 2019 Aug; 45(8):1460-1467. PubMed ID: 31005471
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Unresectable Hepatocellular Carcinoma: Transcatheter Arterial Chemoembolization Combined With Microwave Ablation vs. Combined With Cryoablation.
    Wei J; Cui W; Fan W; Wang Y; Li J
    Front Oncol; 2020; 10():1285. PubMed ID: 32850395
    [No Abstract]   [Full Text] [Related]  

  • 53. Efficacy and Safety of Transarterial Chemoembolization in Elderly Patients of Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Retrospective Study.
    Tang Q; Huang W; Liang J; Xue J
    Front Oncol; 2021; 11():646410. PubMed ID: 34307128
    [TBL] [Abstract][Full Text] [Related]  

  • 54. TACE Plus Lenvatinib Versus TACE Plus Sorafenib for Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Prospective Cohort Study.
    Yang B; Jie L; Yang T; Chen M; Gao Y; Zhang T; Zhang Y; Wu H; Liao Z
    Front Oncol; 2021; 11():821599. PubMed ID: 35004336
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transarterial chemoembolization (TACE) plus apatinib-combined therapy versus TACE alone in the treatment of intermediate to advanced hepatocellular carcinoma patients: A real-world study.
    Wang H; Liu D; Wang C; Yu S; Jin G; Wang C; Zhang B; Zhang D; Shao D
    Clin Res Hepatol Gastroenterol; 2022; 46(6):101869. PubMed ID: 35108656
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transarterial chemoembolization combined with iodine 125 seeds versus transarterial chemoembolization combined with radiofrequency ablation in the treatment of early- and intermediate-stage hepatocellular carcinoma.
    Chen L; Kan X; Sun T; Ren Y; Cao Y; Yan L; Liang B; Xiong B; Zheng C
    BMC Gastroenterol; 2020 Jun; 20(1):205. PubMed ID: 32600349
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessment of efficacy and safety of the transcatheter arterial chemoembolization with or without apatinib in the treatment of large hepatocellular carcinoma.
    Liu J; Xie S; Duan X; Chen J; Zhou X; Li Y; Li Z; Han X
    Cancer Chemother Pharmacol; 2020 Jan; 85(1):69-76. PubMed ID: 31813003
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and safety of transarterial chemoembolization-lenvatinib sequential therapy for the treatment of hepatocellular carcinoma with portal vein tumor thrombus: a retrospective study.
    Chen R; Li Y; Song K; Li L; Shen C; Ma P; Wang Z
    J Gastrointest Oncol; 2022 Apr; 13(2):780-786. PubMed ID: 35557575
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transarterial chemoembolization for hepatocellular carcinoma combined with portal vein tumor thrombosis.
    Lv WF; Liu KC; Lu D; Zhou CZ; Cheng DL; Xiao JK; Zhang XM; Zhang ZF
    Cancer Manag Res; 2018; 10():4719-4726. PubMed ID: 30410405
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transarterial Chemoembolization and Sorafenib Combined with Microwave Ablation for Advanced Primary Hepatocellular Carcinoma: A Preliminary Investigation of Safety and Efficacy.
    Ni JY; Sun HL; Luo JH; Jiang XY; Chen D; Wang WD; Chen YT; Huang JH; Xu LF
    Cancer Manag Res; 2019; 11():9939-9950. PubMed ID: 32063720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.